The new platform lets employers offer GLP-1 drugs like Zepbound at a discounted rate while choosing from a marketplace of administrators.
Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...
Omada Health has released new data indicating that its GLP-1 companion program significantly enhances medication persistence for GLP-1 treatments, which are linked to increased weight loss. The ...
Weight loss is rarely about one missed tray. It usually reflects breakdowns in workflow, observation, communication, and ...